EN – Cryo-Save and Lazaron Biotechnologies establish stem cell bank joint venture in South Africa

June 2, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’), the leading international family stem cell bank, and John Daniel Holdings Ltd (Johannesburg Stock Exchange VCM: JDH), a venture capital company and the controlling shareholder of Lazaron Biotechnologies (SA) Ltd, Africa’s first private cord blood stem cell bank, announced today that the companies signed a memorandum of understanding to establish a new stem cell bank joint venture in South Africa.

read more

NL – Cryo-Save en Lazaron Biotechnologies starten stamcelbank joint venture in Zuid-Afrika

June 2, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’), de toonaangevende internationale familie-stamcelbank, en John Daniel Holdings Ltd (Johannesburg Stock Exchange VCM: JDH), een venture capital onderneming en de controlerend aandeelhouder van Lazaron Biotechnologies (SA) Ltd, de eerste private navelstrengbloed stamcelbank op het Afrikaanse continent, kondigden vandaag aan dat beide bedrijven een Memorandum of Understanding hebben ondertekend voor de oprichting van een nieuwe stamcelbank joint venture in Zuid- Afrika.

read more

Director shareholding

May 27, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international family stem cell bank, has been informed that Mr Arnoud van Tulder, Chief Executive Officer, purchased 2,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price of €5.03 on 24 May 2011.

read more

Cryo-Save on track to launch Cryo-Lip® in the U.S.

May 25, 2011 Group News
Tags

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international family stem cell bank, announces that it has incorporated a wholly owned subsidiary in Delaware, USA. The subsidiary is called Cryo-Save USA, Inc. and will commercialize and further develop the Cryo-Lip® service in North America. Cryo-Lip® allows adults to store stem cells from fat tissue which is extracted whilst undergoing other surgical procedures.

read more

EN – AGM Resolution

May 18, 2011 Group News
Tags
,

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international family stem cell bank, announces that all resolutions at today’s AGM were passed. The following timetable will apply to both the cash dividend of 7 euro cents, withholding 15% dividend tax and the dividend in shares:

read more

NL – AVA Besluiten

May 18, 2011 Group News
Tags
,

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’ of ‘de Groep’), de toonaangevende internationale familie stamcelbank, maakt bekend dat alle voorstellen aan de Algemene Vergadering van Aandeelhouders, welke hedenmiddag plaatsvond te Zutphen, zijn aangenomen.

Het volgende tijdschema is van toepassing op de dividenduitkering van 7 euro cent in contanten, onder inhouding van 15% dividendbelasting en het dividend in aandelen:

read more

EN – Announcement of milestone payment for storing umbilical cord tissue in Serbia and launch in Switzerland

May 17, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international family stem cell bank, announced today the milestone payment of €500,000 as a result of obtaining permission by the competent authorities to start the collection, processing and storing of umbilical cord tissue in Serbia.

read more

NL – Mijlpaal betaling voor de opslag van navelstrengweefsel in Servië en de start in Zwitserland

May 17, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’ of ‘de Groep’), de toonaangevende internationale familie stamcelbank, kondigt vandaag een mijlpaal betaling aan van €500.000 vanwege het verkrijgen van toestemming van de bevoegde autoriteiten in Servië om te starten met de afname, verwerking en opslag van navelstrengweefsel.

read more

EN – Trading update Q1 2011

May 10, 2011 Financial Reports
Tags

Revenue up 8% to €10.4 million and operating profit up 53% to €1.3 million

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international family stem cell bank, announces its trading update for the quarter ended 31 March 2011.

read more